Medicx Health

Canaccord Genuity Advises Medicx Health on its Sale to OptimizeRx

Canaccord Genuity is pleased to announce it has advised Healthy Offers, Inc., dba Medicx Health, a leading healthcare consumer-focused omnichannel marketing and analytics company, on its sale to OptimizeRx Corp. (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients. The transaction purchase price was $95 million, and certain members of Medicx’s management plan to invest approximately $10.5 million of their proceeds into OptimizeRx’s common stock.

Scottsdale, Arizona-based Medicx Health leverages real world evidence with innovative SaaS analytics to drive clinical and commercial strategy and execution with measurable ROI for hundreds of life sciences brands. The company’s patented Micro-Neighborhood® Targeting technology fuels the industry’s highest quality performance for consumer and healthcare provider audiences. Medicx uniquely supports brand and agency clients to plan optimized audience targets and execute efficient omni-channel engagement, as well as measure performance across all channels in a single closed-loop and privacy-compliant environment. 

OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, HCPs, and patients at critical junctures throughout the patient care journey. Connecting more than two million U.S. healthcare providers and millions of their patients through an intelligent technology platform embedded within a proprietary digital point-of-care network, as well as web display and social media, OptimizeRx helps life sciences organizations engage and support their customers.

The acquisition of Medicx further advances OptimizeRx’s mission to create a more informed and empowered healthcare community using new technology solutions. The addition of the Medicx patient and HCP-focused Micro-Neighborhood® Targeting Platform, built on its MX# advanced identity resolution technology, to OptimizeRx’s HCP-focused Dynamic Audience Activation Platform (DAAP) is expected to provide a single source of innovative technologies that will enhance the reach and efficacy of healthcare marketing for life sciences organizations.  In addition, the combined companies’ partnerships encompass most major and emerging media outlets leveraged by healthcare marketers, including advanced tv, programmatic digital display and video, social, digital radio, and digital point-of-care, such as electronic health record (EHR), e-Prescribing, and telehealth platforms.

The merger of Medicx with OptimizeRx is designed to create significant value for customers.  In particular, fast-growing specialty brands looking to educate increasingly specific audiences of patients and HCPs will now be able to link the execution of HCP and consumer marketing strategies together into a truly customer-centric marketing ecosystem.  The combined companies will focus operational integration on the top three areas where clients are looking for long-term partners: new product launch support, increased reach to both HCPs and patients, and sustaining adherence.